PRMT5 and central nervous system cancer: To characterize the expression pattern of Prmt5 in OL lineage cells, we measured its transcript levels in RNA samples obtained from cultured primary oligodendrocyte progenitors (OPCs) kept either in proliferating or differentiating conditions, and compared with values from the immortalized OliNeu cell line or primary glioma cells.